Today’s Nihon Keizai Shimbun (12 April 2008, p.3) has an article on=
the possibility that the basic patent for induced pluripotent stem cells i=
n humans may not go to Shinya Yamanaka, not to the University of Wisconsin,=
but to Bayer.
Both Yamanaka and UW announced the success of iPS cells in humans last Nove=
mber and the presumption is that patent applications were filed prior to th=
ese announcements. But now it has come out that Bayer succeeded with human=
iPS cells earlier in 2007. So if Bayer filed earlier, they may get the ba=
sic patent.
Yamanaka appealed to Japanese nationalism to build a national coalition to =
exploit his iPS success. The JPO agreed to build a dedicated database to h=
elp with patent applications. The Ministry of Education, Culture and Scien=
ce put together a network of universities to work on applications. A pooli=
ng arrangement for patent rights is also in the works. The article specula=
tes that a prior application by Bayer could become a major damper to the na=
tional effort.
The article speculates that Bayer jumped into the game immediately after Ya=
manaka reported success with murine iPS cells in August 2006.
All eyes on PatentScope. Four stars to the searcher who first reports the =
basic publication.
Alan Engel
Paterra, Inc.
2-1-6 Sengen, Tsukuba
Ibaraki 305-0047 Japan
Email: aengel_at_paterra.com
-------------------------------------------
-------------------------------------------
PIUG ® -- Celebrating Our 20th Anniversary
PIUG Discussion List @ Listbox
List owner: Patent Information Users' Group Inc., http://www.piug.org
List rules and guidelines: http://www.piug.org/list.php
List admins: piug_discussion_list-owner(at)v2(dot)listbox(dot)com
3&id_secret=98839165-54a246
_secret=98398157-7da648
Received on Sat Apr 12 2008 - 00:14:01
This archive was generated by hypermail 2.2.0 : Thu Mar 11 2010 - 07:04:12